Recofol®
 | Product: | Recofol® (propofol) injection | | Indication: | Induction and maintenance of general anesthesia (Rx)
Sedation during intensive care (Rx)
Sedation during surgical and diagnostic procedures with local anesthesia (Rx) | | Status: | Marketed |  Licensed from Bayer Schering Pharma, Recofol® was the first of the new class of intravenous anesthetic agents – the alkylphenols – to be commercially introduced in China. It is a sedative-hynoptic agent with rapid onset and recovery, with broad applications in general anesthesia and sedation.
As Recofol® is not an analgesic agent, supplementation with intravenous opioids such as fentanyl or sufentanil is required. Download Recofol Brochure Download Recofol Package Insert |
